Lin M C, Rajfer J, Swerdloff R S, González-Cadavid N F
Department of Surgery, UCLA School of Medicine, Torrance 90509.
J Steroid Biochem Mol Biol. 1993 May;45(5):333-43. doi: 10.1016/0960-0760(93)90002-e.
Androgens down-regulate the levels of androgen receptors (AR) and AR mRNA in the penis and prostate of castrated rats, and are assumed to cause their decrease during sexual maturation in the penile smooth muscle of intact rats. In order to determine whether these effects occur directly at the target cell level, and to what extent they are due to testosterone (T) or to their metabolites, we have measured AR mRNA in cultures of smooth muscle cells from the adult rat corpora cavernosa treated in vitro with sex steroids. T at high concentrations (100 nM) acted like dihydrotestosterone (DHT) in increasing moderately the levels of AR mRNA in both proliferating and contact-inhibited cells. However, when conversion of T to DHT was blocked by the 5-alpha reductase inhibitor finasteride, the levels of AR mRNA were considerably down-regulated by T (10-500 nM), particularly in the contact-inhibited cells. Finasteride by itself was inactive. These effects in both types of cultures were inhibited by platelet derived growth factor (PDGF) (20 ng/ml), a growth factor that up-regulates AR mRNA levels, and by fadrozole (100 nM), an aromatase inhibitor of the T/estrogen conversion. Estradiol (50 nM) was even more potent than T in decreasing AR mRNA levels. With the exception of PDGF none of the treatments affected significantly cell growth, as measured by DNA synthesis and content. Our results indicate that it is possible to modulate in vitro AR mRNA levels in the penile smooth muscle cells, and that under normal conditions DHT and T act as moderate up-regulators. When DHT formation is inhibited, the aromatization pathway of T to estradiol will prevail and induce a pronounced down-regulation of AR mRNA levels. We assume that the in vivo AR down-regulation in the penile smooth muscle by androgens is an indirect effect mediated by a paracrine or endocrine mechanism elicited in another tissue.
雄激素可下调去势大鼠阴茎和前列腺中雄激素受体(AR)及AR mRNA的水平,并且据推测在性成熟过程中,完整大鼠阴茎平滑肌中的AR及AR mRNA水平下降也归因于雄激素。为了确定这些作用是否直接发生在靶细胞水平,以及它们在多大程度上是由睾酮(T)或其代谢产物引起的,我们检测了用性类固醇体外处理的成年大鼠海绵体平滑肌细胞培养物中的AR mRNA。高浓度(100 nM)的T在增殖细胞和接触抑制细胞中均能适度增加AR mRNA水平,其作用类似于双氢睾酮(DHT)。然而,当5-α还原酶抑制剂非那雄胺阻断T向DHT的转化时,T(10 - 500 nM)会使AR mRNA水平显著下调,尤其是在接触抑制细胞中。非那雄胺本身无活性。血小板衍生生长因子(PDGF)(20 ng/ml)和法倔唑(100 nM,一种T/雌激素转化的芳香化酶抑制剂)可抑制这两种培养物中的上述作用,PDGF可上调AR mRNA水平。雌二醇(50 nM)在降低AR mRNA水平方面比T更有效。除PDGF外,其他处理均未显著影响通过DNA合成和含量测定的细胞生长。我们的结果表明,有可能在体外调节阴茎平滑肌细胞中的AR mRNA水平,并且在正常情况下DHT和T起适度上调作用。当DHT形成受到抑制时,T向雌二醇的芳香化途径将占主导并导致AR mRNA水平显著下调。我们推测雄激素在体内对阴茎平滑肌中AR的下调是由另一组织引发的旁分泌或内分泌机制介导的间接效应。